Source: Annual Congress 2001 - Lung cancer: surveys and prognosis



Rating:

Share or cite this content

Citations should be made in the following way:
S. Sohrab, U. Roggenbruck, K. H. Jöckel, N. Konietzko (Essen, Germany). Gender and survival in lung cancer (LC): results of a healthcare study in WestGermany. Eur Respir J 2001; 16: Suppl. 31, 1583

Member's Comments

No comment yet.

Related content which might interest you: Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 TNM and survival in small cell lung cancer: results of a population-based study Source: Eur Respir J 2001; 18: Suppl. 33, 394s Year: 2001 Lung cancer survival in never smokers. Results from the LCRINS study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020 Our operated lung cancer cases and their survival results Source: Eur Respir J 2002; 20: Suppl. 38, 463s Year: 2002 Prospective population-based study on the survival of patients with lung cancer Source: Eur Respir J 2002; 19: 1087-1092 Year: 2002 Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Determinants of the performance status in stage IV nonsmall cell lung cancer - results of a population-based study Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Survival outcomes in advance non-small cell lung cancer – A developing country scenario Source: Annual Congress 2011 - Quality management for lung cancer patients Year: 2011 Time trends in treatment and survival of non-small cell lung cancer in The Netherlands Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Enrolment in clinical trials enhances the survival benefit provided to lung cancer patients Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Epidemiological and clinical predictors of survival during the first year of the treatment in non-small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Prognostic impact of socioeconomic status and health care access in non small cell lung cancer (NSCLC) Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Chemotherapy improves low performance status lung cancer patients Source: Eur Respir J 2007; 30: 1186-1192 Year: 2007 Symptom control in advanced non-small cell lung cancer (NSCLC): what is the influence of cisplatin-use, age, performance status and duration of chemotherapy? Analysis of a randomized database Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2011; 39: 9-28 Year: 2012 Surrogate markers predicting overall survival for lung cancer: ELCWP recommendations Source: Eur Respir J 2012; 39: 9-28 Year: 2012 A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery Year: 2015 The influence of secondary infectious process on non-small cell lung cancer (NSCLC) patients survival Source: Eur Respir J 2007; 30: Suppl. 51, 280s Year: 2007 Lung cancer and socioeconomic status: Differences in demographics, stage, treatment and mortality in a lung cancer centre Source: International Congress 2015 – Quality management in lung cancer Year: 2015